Molecular pathways: human leukocyte antigen G (HLA-G)

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Human leukocyte antigen G (HLA-G) is a nonclassical MHC class I molecule with critical tolerogenic functions.
• Physiologically expressed in the placenta, HLA-G facilitates maternal tolerance of the fetus.
• HLA-G is also found in embryonic tissues, immune-privileged organs, and hematopoietic cells.

Purpose of the Study:

• To review HLA-G expression in various cancers and its association with patient prognosis.
• To elucidate the molecular mechanisms behind impaired HLA-G expression in tumors.
• To discuss the diagnostic potential of HLA-G as a biomarker and its therapeutic implications in cancer.

Main Methods:

• Review of existing literature on HLA-G expression in primary solid and hematologic malignancies.
• Analysis of studies investigating the role of HLA-G in tumor immune evasion.
• Examination of research on HLA-G as a diagnostic biomarker and therapeutic target.

Main Results:

• Ectopic expression of HLA-G is observed in diverse cancers, suggesting a role in immune escape.
• HLA-G expression is linked to tumor progression and poorer prognosis in several malignancies.
• Both membrane-bound and soluble forms of HLA-G show potential as diagnostic and prognostic biomarkers.

Conclusions:

• Tumor cells utilize HLA-G to evade immune surveillance, contributing to cancer progression.
• HLA-G represents a promising biomarker for cancer diagnosis, staging, and monitoring.
• Targeting HLA-G offers a potential therapeutic strategy to enhance the efficacy of anticancer treatments.